Characteristics of COVID-19 and mortality-associated factors during the first year of the pandemic in southeast Mexico.
Rangel-Méndez Jorge-AarónLuciola Jaimes-GurrusquietaJuan F Sánchez-CruzMa I Zarate-MurilloJessica Domínguez-MéndezHugo A Laviada-MolinaDaniel Casares-GonzálezElideth M Flores-FloresPublished in: Future microbiology (2023)
Aim: The present study was designed to evaluate the clinical characteristics of COVID-19 and mortality-associated factors during the first year of the pandemic in patients from southeastern Mexico. Patient & methods: A total of 953 records from patients with COVID-19 were cross-sectionally studied in a primary care hospital in southeast Mexico between 2020 and 2021. Results: The prevalent symptoms were fever (78.6%), cough (80.5%) and headache (82.8%) and dyspnea reached 13.5%. The mortality rate was 7.63% and the clinical variables associated with it were age >60 years, hypertension, severe disease, radiographic pneumonia, days to diagnosis and having two Mayan surnames. Conclusion: Future health strategies should consider age, comorbidities, disease severity, clinical manifestations and possessing ethnicity of risk (i.e., Mayan genetic background).
Keyphrases
- coronavirus disease
- sars cov
- primary care
- cardiovascular events
- end stage renal disease
- healthcare
- risk factors
- blood pressure
- newly diagnosed
- chronic kidney disease
- respiratory syndrome coronavirus
- mental health
- prognostic factors
- emergency department
- cardiovascular disease
- peritoneal dialysis
- type diabetes
- health information
- genome wide
- depressive symptoms
- coronary artery disease
- physical activity
- patient reported outcomes
- palliative care
- current status
- extracorporeal membrane oxygenation
- climate change
- sleep quality
- patient reported
- acute respiratory distress syndrome
- human health
- acute care
- adverse drug
- advanced cancer
- respiratory failure